The partnership is intended to accelerate the development of advanced technologies around a shared goal: delivering measurable value to customers, expanding market coverage, and enabling faster innovation. Within this framework, Marchesini Group has acquired a 44.39% equity stake in AST, reinforcing its aseptic packaging offering. AST brings high-end aseptic filling and closing systems for pharmaceutical and biotech manufacturing. These capabilities will integrate with the technologies developed within Marchesini Group’s two production sites: Corima, based in Tuscany and focused on sterile product filling, and MAR, specialized in precision filling and capping machines for liquid and powder products.
Expanding the market presence without losing local markets
Valerio Soli, CEO of Marchesini Group (on the left) and Joe Hoff, CEO of AST. (photo: Marchesini)
By leveraging the heritage and strength of both brands, the partnership will expand market presence without losing connection to local markets. Both companies share a commitment to operational excellence, innovation, and long-term value creation. This partnership unites two strong organizations with complementary capabilities, enabling greater efficiency, enhanced market presence, and the realization of significant synergies.
